The Ted Rogers Centre for Heart Research is thrilled to welcome Dr. Cedric Manlhiot as the inaugural Rogers Innovator of Cardiovascular Precision Medicine at SickKids. In addition to his role at TRCHR, Dr. Manlhiot will be a Scientist in the Translational Medicine...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Launching in March 2024, emergency department (ED) physicians at the University Health Network (UHN) can now access the Emergency Heart Failure Mortality Risk Grade (EHMRG) calculator within Epic, UHN’s electronic medical record. The EHMRG score estimates the risk of...
Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
Three bold projects target special challenges in HF
PIONEER 6 finds novel GLP-1 RA is safe for the heart
New genetic insights and pipelines for discovery
Collaborative Ted Rogers Centre has taken new aim at heart failure
How clonal hematopoiesis may drive heart disease
To admit or discharge is of huge consequence
Medly program paves way for new model of care in HF
By suppressing the protein gelsolin, heart function is preserved.
Video: Dr. David Fitchett explores a key subject
Education Fund helps support novel research
